Medical Technologies

Control Material for Quality Assurance of Qualitative Determination of Hepatitis B Virus e-Antigen (HBeAg) in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers

Control Material for Quality Assurance of Qualitative Determination of Hepatitis B Virus e-Antigen (HBeAg) in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers

Control material designed to ensure quality assurance for the qualitative detection of HBeAg using chemiluminescent immunoassay on CL series analyzers is available in the following formats:

Variant 1: Negative Control Material

Negative control material for qualitative HBeAg determination in clinical samples via chemiluminescent immunoassay on CL series analyzers.

  • Packaging: 3 vials × 2.0 mL each
  • Contents:
    • HBeAg Negative Control, 2.0 mL – 3 vials
    • Control material value chart
    • Instructions for use

Variant 2: Negative Control Material

Negative control material for qualitative HBeAg determination in clinical samples via chemiluminescent immunoassay on CL series analyzers.

  • Packaging: 6 vials × 2.0 mL each
  • Contents:
    • HBeAg Negative Control, 2.0 mL – 6 vials
    • Control material value chart
    • Instructions for use

Variant 3: Positive Control Material

Positive control material for qualitative HBeAg determination in clinical samples via chemiluminescent immunoassay on CL series analyzers.

  • Packaging: 3 vials × 2.0 mL each
  • Contents:
    • HBeAg Positive Control, 2.0 mL – 3 vials
    • Control material value chart
    • Instructions for use

Variant 4: Positive Control Material

Positive control material for qualitative HBeAg determination in clinical samples via chemiluminescent immunoassay on CL series analyzers.

  • Packaging: 6 vials × 2.0 mL each
  • Contents:
    • HBeAg Positive Control, 2.0 mL – 6 vials
    • Control material value chart
    • Instructions for use

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Control Material for Quality Assurance of Qualitative Determination of Hepatitis B Virus e-Antigen (HBeAg) in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Copyright MAXXmarketing GmbH
JoomShopping Download & Support